Montelukast in chronic lung allograft dysfunction after lung transplantation

Chronic lung allograft dysfunction (CLAD) is a major cause of post-lung transplant mortality with limited medical treatment options. We assessed the association of montelukast treatment with pulmonary function and outcome in lung transplant recipients with progressive CLAD.

Source: The Journal of Heart and Lung Transplantation - December 7, 2018 Category: Transplant Surgery Authors: Robin Vos, Ruben Vanden Eynde, David Ruttens, Stijn E. Verleden, Bart M. Vanaudenaerde, Lieven J. Dupont, Jonas Yserbyt, Eric K. Verbeken, Arne P. Neyrinck, Dirk E. Van Raemdonck, Geert M. Verleden, The Leuven Lung Transplant Group Source Type: research